Professor, Medicine, UCLA School of Medicine
Gastroenterology
Dr. Viktor Eysselein, MD
|
|
Give Review
Viktor Eysselein works in the field of Gastroenterology. He received awards:"Top Doctors:LA Area", "Fellow (FACG)" and "Super Doctor". Viktor Eysselein is a published MD. He has 89 publications published. The most current publication "Differential expression and localization of IGF-I and IGF binding proteins in inflamed rat colon." He accepts all Medicare patients.
Publications
- Evaluation of fully covered self-expanding metal stents in Benign biliary strictures and bile leaks.
- Fluid Genetic Analyses Predict the Biological Behavior of Pancreatic Cysts: Three-year Experience.
- [Discovery of cholecystokinin-58: isolation from the small intestine and brain, structural analysis, biologic activity and liberation into circulating blood].
- Determination of various molecular forms of cholecystokinin from canine mucosa by radioimmunoassay and bioassay.
- Gastrin is not a physiological regulator of pancreatic exocrine secretion in the dog.
- Molecular heterogeneity of canine cholecystokinin in portal and peripheral plasma.
- Calcitonin gene-related peptide and substance P decrease in the rabbit colon during colitis. A time study.
- Protective function of extrinsic sensory neurons in acute rabbit experimental colitis.
- [Sensory neuropeptides: pro-inflammatory or protective effect in the intestine?].
- Up-regulation of insulinlike growth factor I binding sites in experimental colitis in rats.
- Mice lacking transforming growth factor alpha have an increased susceptibility to dextran sulfate-induced colitis.
- Pancreatic and Gastric responses to Gastric versus jejunal beer in humans.
- Action of intravenous ethanol and atropine on the secretion of gastric acid, pancreatic enzymes, and bile acids and the motility of the upper gastroIntestinal tract in...
- Expression of insulin-like growth factor I receptors and binding proteins by colonic smooth muscle cells.
- Substance P and CGRP mediate motor Response of rabbit colon to capsaicin.
- Action of neurotensin on meal-stimulated Gastric acid secretion in the dog.
- Reduction of stress--a new therapeutic goal in the treatment of inflammatory bowel Disease?
- Keratinocyte growth factor promotes healing of left-sided colon anastomoses.
- Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats.
- Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit Immune complex colitis.
- Mechanisms of cAMP-mediated relaxation of distal circular muscle in rabbit colon.
- An abnormal rate of actin myosin cross-bridge cycling in colonic smooth muscle associated with experimental colitis.
- [Animal experiment models of chronic inflammatory bowel Diseases].
- Hereditary error in epidermal growth factor prohormone metabolism in a rat model of autosomal dominant polycystic kidney Disease.
- Calcitonin gene-related peptide in inflammatory bowel Disease and experimentally induced colitis.
- Cholecystokinin--gene structure, and molecular forms in tissue and blood.
- Characterization of two forms of peptide YY, PYY(1-36) and PYY(3-36), in the rabbit.
- [Pro34]peptide YY is a Y1-selective agonist at peptide YY/neuropeptide Y receptors.
- New molecular forms of cholecystokinin. Microsequence analysis of forms previously characterized by chromatographic methods.
- [Proteolytic processing by dipeptidyl aminopeptidase IV generates receptor selectivity for peptide YY (PYY)].
- Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36.
- [Y1 receptors mediate inhibitory and stimulatory effects of peptide YY in isolated small intestine and large intestine muscles of the rabbit].
- Transforming growth factor-alpha (TGF-alpha) is not needed for malignant transformation in experimental colitis.
- Increased expression of epidermal growth factor-receptor in an experimental model of colitis in rats.
- Regulation of gastric acid secretion by gastrin in Duodenal ulcer patients and healthy subjects.
- Increased expression of transforming growth factor alpha precursors in acute experimental colitis in rats.
- Epidermal growth factor increases basal mucosal blood flow in the rat colon, a prostaglandin dependent effect.
- Keratinocyte growth factor ameliorates dextran sodium sulfate colitis in mice.
- Proteolytic release of membrane bound intercellular regulators.
- Differential expression and localization of IGF-I and IGF binding proteins in inflamed rat colon.
- Transforming growth factor alpha-immunoreactivity in neural tissues of the rat stomach.
- A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36).
- Selective ablation of spinal afferent neurons containing CGRP attenuates Gastric hyperemic response to acid.
- Accelerated in vitro degradation of CCK-58 in blood and plasma of patients with acute pancreatitis.
- Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's Disease.
- Isolation and characterization of a neurotensin-like decapeptide from a canine upper small Intestinal extract.
- Biological activity of canine Intestinal cholecystokinin-58.
- Isolation and characterization of biologically active and inactive cholecystokinin-octapeptides from human brain.
- Detection of cholecystokinin-58 in human blood by inhibition of degradation.
- Partial structure of a large canine cholecystokinin (CCK58): amino acid sequence.
- Comparison of clearance and metabolism of infused cholecystokinins 8 and 58 in dogs.
- Inhibition of canine exocrine pancreatic secretion by peptide YY is mediated by PYY-preferring Y2 receptors.
- Isolation of a large cholecystokinin precursor from canine brain.
- Protective effect of epidermal growth factor in an experimental model of colitis in rats.
- Cholecystokinin-58 is the major molecular form in man, dog and cat but not in pig, beef and rat intestine.
- Action of sensory neurons in an experimental at colitis model of injury and repair.
- Reduced susceptibility of mice overexpressing transforming growth factor alpha to dextran sodium sulphate induced colitis.
- Inhibitory effect of PYY on vagally stimulated acid secretion is mediated predominantly by Y1 receptors.
- Structural characterization of calcitonin gene-related peptide purified from rabbit intestine.
- Molecular variants of cholecystokinin after endogenous stimulation in humans: a time study.
- Patterns of prohormone processing. Order revealed by a new procholecystokinin-derived peptide.
- Staining for intracytoplasmic lumina and CAM5.2 increases the detection rate for bile duct Cancers.
- Case of Boerhaave's Syndrome successfully treated with a self-expandable metallic stent.
- Peptide YY inhibits exocrine pancreatic secretion in isolated perfused rat pancreas by Y1 receptors.
- CCK-5: sequence analysis of a small cholecystokinin from canine brain and intestine.
- Cholecystokinin-58 is the major circulating form of cholecystokinin in canine blood.
- Colonic stents in Colorectal obstruction.
- An amino-terminal fragment of cholecystokinin-58 is present in the gut: evidence for a similar processing site of procholecystokinin in canine gut and brain.
- Structural characterization of canine PYY.
- Natural and synthetic CCK-58. Novel reagents for studying cholecystokinin physiology.
- Characterization of the major form of cholecystokinin in human intestine: CCK-58.
- Evidence that CCK-58 has structure that influences its biological activity.
- Characterization of canine Intestinal cholecystokinin-58 lacking its carboxyl-terminal nonapeptide. Evidence for similar post-translational processing in brain and gut.
- Pilot series of radiofrequency ablation of Barrett''s Esophagus with or without neoplasia.
- The ADH3*2 and CYP2E1 c2 alleles increase the risk of alcoholism in Mexican American men.
- Acute liver injury induced by weight-loss herbal supplements.
- An Enzyte'ing' case of acute Hepatitis.
- Palliation of patients with dysphagia due to advanced esophageal Cancer by endoscopic injection of cisplatin/epinephrine injectable gel.
- Fluorescence In Situ Hybridization and K-ras Analyses Improve Diagnostic Yield of Endoscopic Ultrasound-Guided Fine-Needle Aspiration of Solid Pancreatic Masses.
- Staining for p53 and Ki-67 increases the sensitivity of EUS-FNA to detect pancreatic malignancy.
- Improved oral intake after palliative Duodenal stenting for malignant obstruction: a prospective multicenter clinical trial.
- The value of endoscopic ultrasonography in predicting resectability and margins of resection for periampullary tumors.
- Circumferential ablation of Barrett''s Esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry.
- Evolution of fine needle aspiration cytology in the accurate diagnosis of pancreatic Neoplasms.
- Hepatitis C infection in dialysis patients: a link to poor clinical outcome?
- The role of radiologic studies in the diagnosis of mesenteric ischemia.
- CCK-58 is the only detectable endocrine form of cholecystokinin in rat.
- EUS-guided pancreatic pseudocyst drainage: review and experience at Harbor-UCLA Medical Center.
Schools
JuliusMaximiliansUniversitaet Wurzburg Medizinische Fakultat
University Ulm
University Essen
University Of California Los Angeles
University Of Essen
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Liver Biopsy
- View All
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- Top Doctors:LA Area
- Fellow (FACG)
- Super Doctor
Hospital
-
Ronald Reagan UCLA Medical Center -
Harbor-UCLA Medical Center -
Torrance Memorial Medical Center
Drug Facts
| NPI NUMBER | 1609848191 | |
| NPPES Provider LastName | EYSSELEIN | |
| NPPES Provider FirstName | VIKTOR | |
| NPPES Provider ZIPCode | 905022047 | |
| NPPES Provider State | CA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 462.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 2.81 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609848191 |
| Last Name Of The Provider | EYSSELEIN |
| First Name Of The Provider | VIKTOR |
| View All |
Similar Doctors
|
|
Dr. Tonny M. Lee, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Steven Weinstock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sutha Sachar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Judy L. Law-Torok, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thai Q. Ha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shahina Hakim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph S. Tan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Chung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas L. Hunt, MD |
|
Dr. Susanna M. Chan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Iraj Akhlaghi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George B. Gershman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric N. Lau, MD |
|
|
Dr. Disaya Chavalitdhamrong, MD |